Literature DB >> 21109513

Cardiovascular disease in rheumatoid arthritis: state of the art and future perspectives.

George D Kitas1, Sherine E Gabriel.   

Abstract

Rheumatoid arthritis is associated with an increased risk for cardiovascular events, such as myocardial infarction and stroke. Epidemiological evidence suggests that classic cardiovascular risk factors, such as hypertension, dyslipidaemia, insulin resistance and body composition alterations are important but not sufficient to explain all of the excess risk. High-grade systemic inflammation and its interplay with classic risk factors may also contribute. Some associations between classic risk factors and cardiovascular risk in people with rheumatoid arthritis appear counterintuitive but may be explained on the basis of biological alterations. More research is necessary to uncover the exact mechanisms responsible for this phenomenon, develop accurate systems used to identify patients at high risk, design and assess prevention strategies specific to this population of patients.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109513     DOI: 10.1136/ard.2010.142133

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  116 in total

1.  Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis.

Authors:  Bryant R England; Joshua F Baker; Harlan Sayles; Kaleb Michaud; Liron Caplan; Lisa A Davis; Grant W Cannon; Brian C Sauer; E Blair Solow; Andreas M Reimold; Gail S Kerr; Ted R Mikuls
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-12-06       Impact factor: 4.794

Review 2.  Adaptive immunity in atherogenesis: new insights and therapeutic approaches.

Authors:  Andrew H Lichtman; Christoph J Binder; Sotirios Tsimikas; Joseph L Witztum
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

Review 3.  A critical view on cardiovascular risk in systemic sclerosis.

Authors:  Antonios Psarras; Stergios Soulaidopoulos; Alexandros Garyfallos; George Kitas; Theodoros Dimitroulas
Journal:  Rheumatol Int       Date:  2016-07-12       Impact factor: 2.631

4.  Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study.

Authors:  Charalampos Papagoras; Kerstin Achenbach; Niki Tsifetaki; Spyridon Tsiouris; Andreas Fotopoulos; Alexandros A Drosos
Journal:  Clin Rheumatol       Date:  2014-05-22       Impact factor: 2.980

Review 5.  Regulation of atherogenesis by chemokine receptor CCR6.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Trends Cardiovasc Med       Date:  2011-07       Impact factor: 6.677

Review 6.  IL-6 biology: implications for clinical targeting in rheumatic disease.

Authors:  Leonard H Calabrese; Stefan Rose-John
Journal:  Nat Rev Rheumatol       Date:  2014-08-19       Impact factor: 20.543

Review 7.  Cardiovascular risk and the use of biologic agents in rheumatoid arthritis.

Authors:  Debbie T Lim; Amy C Cannella; Kaleb D Michaud; Ted R Mikuls
Journal:  Curr Rheumatol Rep       Date:  2014-11       Impact factor: 4.592

8.  Resveratrol prevents atrial fibrillation by inhibiting atrial structural and metabolic remodeling in collagen-induced arthritis rats.

Authors:  Yun Zhang; Song Zhang; Zonghong Liu; Xinbo Zhao; Yue Yuan; Li Sheng; Yue Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-22       Impact factor: 3.000

Review 9.  G protein signaling modulator-3: a leukocyte regulator of inflammation in health and disease.

Authors:  Matthew J Billard; Bryan J Gall; Kristy L Richards; David P Siderovski; Teresa K Tarrant
Journal:  Am J Clin Exp Immunol       Date:  2014-08-15

10.  Derangement of hemostasis in rheumatoid arthritis: association with demographic, inflammatory and metabolic factors.

Authors:  Theodoros Dimitroulas; Karen M J Douglas; Vasileios F Panoulas; Tracey Toms; Jacqueline P Smith; Gareth J Treharne; Peter Nightingale; James Hodson; George D Kitas
Journal:  Clin Rheumatol       Date:  2013-05-15       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.